Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study is being done to find out if the combination of VelcadeTM with melphalan and
dexamethasone (VMD) will be as effective, or even more effective as it is in combination with
thalidomide and dexamethasone (VTD).